Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH.
Maria Nicoline Baandrup KristiansenSanne Skovgård VeidalChristina ChristoffersenMichael FeighNiels VrangJonathan David RothMary EricksonLuciano AdoriniJacob JelsingPublished in: BMC gastroenterology (2019)
In conclusion, in-depth analyses of liver homogeneity demonstrated that drug-induced improvement in liver biopsy-assessed histopathology is representative for overall liver effects assessed using stereology. Importantly, these findings reveal how changes in whole-liver mass should be considered to provide a deeper understanding of apparent drug treatment efficacy in preclinical NASH studies.
Keyphrases
- drug induced
- liver injury
- mouse model
- ultrasound guided
- fine needle aspiration
- type diabetes
- metabolic syndrome
- adipose tissue
- adverse drug
- emergency department
- magnetic resonance imaging
- cross sectional
- mesenchymal stem cells
- optical coherence tomography
- single cell
- magnetic resonance
- bariatric surgery
- resting state
- bone marrow
- functional connectivity
- combination therapy